Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
US Army
Mallinckrodt
Cipla
Chinese Patent Office
Fuji
Covington
AstraZeneca
Merck

Generated: October 16, 2017

DrugPatentWatch Database Preview

FLOXIN OTIC Drug Profile

« Back to Dashboard

Which patents cover Floxin Otic, and what generic Floxin Otic alternatives are available?

Floxin Otic is a drug marketed by Daiichi and is included in one NDA.

The generic ingredient in FLOXIN OTIC is ofloxacin. There are seventy-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.

Summary for Tradename: FLOXIN OTIC

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list77
Clinical Trials: see list41
Patent Applications: see list5,576
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLOXIN OTIC at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi
FLOXIN OTIC
ofloxacin
SOLUTION/DROPS;OTIC020799-001Dec 16, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FLOXIN OTIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi
FLOXIN OTIC
ofloxacin
SOLUTION/DROPS;OTIC020799-001Dec 16, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Express Scripts
Boehringer Ingelheim
Chubb
Merck
Cerilliant
Citi
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot